Renal denervation lowers BP in Black patients with resistant hypertension at 3 years

In Black patients with resistant hypertension, renal denervation was associated with reductions in systolic BP at 3 years, according to new data from the SYMPLICITY HTN-3 trial. As Healio previously reported, in the main results of SYMPLICITY HTN-3, the renal denervation system (Symplicity, Medtronic) did not significantly lower office systolic BP at 6 months compared with a sham procedure.

Related Keywords

United States , Washington , Richard Smith , Byerik Swain , Deepakl Bhatt , Cardiovascular Research Technologies , Icahn School Of Medicine At Mount Sinai , Medtronic , Breaking Trials , Today Intervention Section Editor Deepak , Mount Sinai Heart , Valentin Fuster Professor , Cardiovascular Medicine , Icahn School , Mount Sinai , Cardiovascular Research ,